HDAC4 and amyotrophic lateral sclerosis: In humans HDAC4 is up-regulated in ALS patients featuring a rapidly progressive disease compared with long-term survivors, while MIR206 is up-regulated in both patient groups, although its levels do not correlate with the disease progression9.